Organisation paid for research Program year 2025 Source: CMS Open Payments

Phoenix Cardiovascular

Neither a doctor nor a teaching hospital

Research payments

$414,175

93 payments

Through program year 2025, Phoenix Cardiovascular is reported as receiving $414,175 in research payments, across 93 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$10,335	4
2024	Research	$26,600	5
2023	Research	$39,786	9
2022	Research	$29,010	6
2021	Research	$58,018	18
2020	Research	$137,912	27
2019	Research	$112,516	24

Breakdown

Who paid Research payments · program years 2019–2025

Abbott Laboratories $414,175 93 payments

Studies the money was for Research payments · program years 2019–2025

Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal $81,092 18 payments
Hemodynamic-GUIDEd Management of Heart Failure $59,913 5 payments
Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) $42,307 6 payments
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal (TRILUMINATE) $39,066 7 payments
Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal $34,350 7 payments
A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip Devices $25,799 4 payments
XIENCE 28 USA Study $22,825 5 payments
Optisure Lead Post Approval Study $21,981 4 payments
Hemodynamic Guided Monitoring in Heart Failure (HF) Trial $21,115 4 payments
Xience Short Dapt 28 US $12,525 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.